Australia
Telix Pharmaceuticals Completes BLA Submission to FDA for Breakthrough Kidney Cancer Imaging Agent TLX250-CDx
Telix Pharmaceuticals announces that it has completed the submission of a Biologics License Application (BLA) to the United States (U.S.) Food an...
June 03, 2024 | News
LumaCina to Produce Oral Morphine Amidst Critical Shortage in New Zealand
LumaCina, the pharmaceutical supplier and marketing division of Bridgewest Perth Pharma announce new production of Oral Morphine to meet cr...
May 31, 2024 | News
Monash University and Thermo Fisher Scientific Forge New Partnership to Propel Scientific Advancements
Marking an exciting new chapter in a long-standing relationship, Monash University has entered into a Memorandum of Understanding with Thermo Fisher Scient...
May 30, 2024 | News
SK Telecom Launches AI-Based Veterinary X-Ray Service 'X Caliber' in Australia
In collaboration with ATX Medical Solutions, SKT launches X Caliber in Australia, which has one of the highest rates of pet ownership in the world ...
May 29, 2024 | News
Neuren Pharmaceuticals Announces Positive Phase 2 Trial Results for NNZ-2591 in Pitt Hopkins Syndrome
Neuren Pharmaceuticals revealed top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Pitt Hopkins syndrome (PTHS). This trial demo...
May 28, 2024 | News
Telix Pharmaceuticals Submits NDA for Innovative Prostate Cancer Imaging Kit to FDA
Telix Pharmaceuticals announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA...
May 27, 2024 | News
Envac Wins €10 Million Contracts to Enhance Waste Management in French Hospitals
Smart waste management in hospitals has been increasingly important for achieving the higher standards of safety and environmental expectation required by ...
May 22, 2024 | News
BeiGene and Glenmark Forge Strategic Partnership to Distribute Innovative Cancer Treatments in India
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced a new partnership with Glenmark Specialty S.A. (Glen...
May 21, 2024 | News
Telix Pharmaceuticals' CUPID Study Demonstrates Promising Results for Next-Generation Prostate Cancer Therapy
CUPID is a Phase I safety and dosimetry study of TLX592, Telix's investigational antibody-based targeted alpha therapy for prostate cancer. Establishes ...
May 21, 2024 | News
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
“Approval of the Axonics recharge-free system is welcome news for Australians with bladder and bowel dysfunction,” said...
May 17, 2024 | News
NeuShen Therapeutics Begins Phase I Trial of NS-136, a Potential Breakthrough in Schizophrenia Treatment
NeuShen Therapeutics , a clinical-stage global biotechnology company dedicated to pioneering treatments for neurological and psychiatric disorders, today a...
May 10, 2024 | News
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open ...
May 08, 2024 | News
Alnylam and Medison Expand Global Partnership to Accelerate Access to Innovative Therapies
The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one glo...
May 01, 2024 | News
FDA Approves Ractigen Therapeutics' IND for Groundbreaking Bladder Cancer Therapy
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration...
April 29, 2024 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
